Tacrolimus Streptavidin Conjugate (PEG Linker)

<strong>Tacrolimus Streptavidin Conjugate Solution [PEG Linker]_x000D_ </strong>_x000D_ <table width="452">_x000D_ <tbody>_x000D_ <tr>_x000D_ <td><strong>Catalog #</strong></td>_x000D_ <td>P2010028</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td><strong>Size</strong></td>_x000D_ <td>1.00 mg</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td><strong>Other Names</strong></td>_x000D_ <td>Streptavidin-Tacrolimus, Tacrolimus_Streptavidin, Streptavidin conjugated to Tacrolimus, FK506-Streptavidin, Streptavidin-FK506, Tacrolimus_Streptavidin Conjugate, Tacrolimus [Streptavidin].</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td><strong>Molecular Weight</strong></td>_x000D_ <td>54.1 kDa (average)</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td><strong>Concentration</strong></td>_x000D_ <td>1.0 mg/mL</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td><strong>Purity</strong></td>_x000D_ <td>&gt;95%</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td><strong>Storage</strong></td>_x000D_ <td>-20°C. Avoid repeated freeze/thaw cycles.</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td><strong>Supplied as</strong></td>_x000D_ <td>Liquid solution</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td><strong>Buffer</strong></td>_x000D_ <td>1X Phosphate Buffer Saline, pH 7.4.</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td><strong>Keywords</strong></td>_x000D_ <td>Streptavidin conjugate, Tacrolimus 32, Tacrolimus, FK-506, Fujimycin, Prograf, Advagraf, Protopic</td>_x000D_ </tr>_x000D_ </tbody>_x000D_ </table>_x000D_ &nbsp;_x000D_ _x000D_ <a href="https://moleculardepot.com/wp-content/uploads/2021/09/MKT-008-Tacrolimus-Brochure.pdf"><strong>Complete Tacrolimus Product Line</strong></a>_x000D_ _x000D_ <a href="https://moleculardepot.com/wp-content/uploads/2021/09/MKT-008-Tacrolimus-Brochure.pdf">Download Brochure</a>_x000D_ _x000D_ <a href="https://moleculardepot.com/wp-content/uploads/2021/09/MKT-008-Tacrolimus-Brochure.pdf"><img class="media-library__list-item-centered is-image" draggable="false" src="https://i0.wp.com/moleculardepot.com/wp-content/uploads/2019/02/cropped-LogoHD-3.png?ssl=1&amp;resize=438,438" alt="cropped-LogoHD-3.png" width="94" height="94" /></a>_x000D_ _x000D_ <strong>References</strong>_x000D_ <ul>_x000D_ <li>Brunet, M., Plana, J. C., and Rimola, A. (2001). <em>Tacrolimus</em>. Madrid: Drug Farma.</li>_x000D_ <li>Goto, T., and Nakagawa, H. (2004). Development of Tacrolimus Ointment. <em>Tacrolimus Ointment</em>, 81–98.</li>_x000D_ <li>Raptis, D., and Pramateftakis, M.-G. (2013). <em>Tacrolimus: Effectiveness, safety and drug interactions</em>. New York: Nova Biomedical.</li>_x000D_ <li>Plosker, G. L., and Foster, R. H. (2001). <em>Tacrolimus a further update of its pharmacology and therapeutic use in the management of organ transplantation</em>. Auckland: ADIS International.</li>_x000D_ <li>Kaplan, B., Burckart, G. J., and Lakkis, F. G. (2012). <em>Immunotherapy in transplantation: principles and practice</em>. Chichester, West Sussex, UK: Wiley Blackwell.</li>_x000D_ <li>Oberbauer R, Bestard O, Furian L, Maggiore U, Pascual J, Rostaing L, Budde K. Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives. <a href="https://www.ncbi.nlm.nih.gov/pubmed/31955920"><span class="jrnl" title="Transplantation reviews (Orlando, Fla.)">Transplant Rev (Orlando)</span>.</a> 2020 Jan 13:100531.</li>_x000D_ <li>Sanches-Silva A, Testai L, Nabavi SF, Battino M, Pandima Devi K, Tejada S, Sureda A, Xu S, Yousefi B, Majidinia M, Russo GL, Efferth T, Nabavi SM, Farzaei MH. Therapeutic potential of polyphenols in cardiovascular diseases: Regulation of mTOR signaling pathway. <span class="jrnl" title="Pharmacological research">Pharmacol Res</span>. 2020 Feb;152:104626.</li>_x000D_ <li>Akbari M, Soltani Moghadam R, Elmi R, Nosrati A, Taghiabadi E, Aghdami N. Topical Tacrolimus as an adjunct to Conventional Therapy for Stromal Herpetic Keratitis: a Randomized Clinical Trial. <span class="jrnl" title="Journal of ophthalmic &amp; vision research">J Ophthalmic Vis Res</span>. 2019 Oct 24;14(4):400-411.</li>_x000D_ <li>Plasmeijer EI, Sachse MM, Gebhardt C, Geusau A, Bouwes Bavinck JN. Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance - the impact of immunosuppression on frequency of cSCC. <span class="jrnl" title="Journal of the European Academy of Dermatology and Venereology : JEADV">J Eur Acad Dermatol Venereol</span>. 2019 Dec;33 Suppl 8:33-37.</li>_x000D_ </ul>_x000D_ <strong>Related Products</strong>_x000D_ _x000D_ https://moleculardepot.com/product/tacrolimus-streptavidin-conjugate-peg11-linker/_x000D_ _x000D_ https://moleculardepot.com/product/tacrolimus-bsa-conjugate-p2010001/_x000D_ _x000D_ https://moleculardepot.com/product/biotinylated-tacrolimus-bsa-conjugate/_x000D_ _x000D_ https://moleculardepot.com/product/tacrolimus-biotin-conjugate-biotinylated-tacrolimus/_x000D_ _x000D_ https://moleculardepot.com/product/tacrolimus-biotin-conjugate-peg11-spacer/